Publication | Closed Access
Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma
26
Citations
25
References
2019
Year
OncologyMedicinePathologyPreclinical EfficacyLiver CancerCancer TreatmentPharmacologyRadiation OncologyHepatocellular Carcinoma
| Year | Citations | |
|---|---|---|
Page 1
Page 1